SAN DIEGO, CA, April- LAWFUEL — Nventa Biopharmaceuticals Corporatio…
SAN DIEGO, CA, April- LAWFUEL — Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today that the U.S. Patent and Trademark Office has issued Reexamination Certificates for patents U.S. 6,335,183 and U.S. 6,338,952, concluding the ex-parte reexaminations process, and allowing both patents to be maintained in amended form. These patents form the basis of Nventa’s proprietary CoVal(TM)
SAN DIEGO, CA, April- LAWFUEL — Nventa Biopharmaceuticals Corporatio… Read More »